Cargando…

Subtype-Based Microbial Analysis in Non-small Cell Lung Cancer

BACKGROUND: The human lung serves as a niche for a unique and dynamic bacterial community related to the development and aggravation of multiple respiratory diseases. Therefore, identifying the microbiome status is crucial to maintaining the microecological balance and maximizing the therapeutic eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Hye Jin, Lee, Eunkyung, Cho, Young-Jae, Lee, Sang Hoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555521/ https://www.ncbi.nlm.nih.gov/pubmed/37345463 http://dx.doi.org/10.4046/trd.2022.0149

Ejemplares similares

Multi-institutional analysis of T3 subtypes and adjuvant radiotherapy effects in resected T3N0 non-small cell lung cancer patients
por: Choi, Yunseon, et al.
Publicado: (2015)

Prognosis of non-small-cell lung cancer in patients with idiopathic pulmonary fibrosis
por: Han, SongYi, et al.
Publicado: (2019)

New Targeted Therapy for Non-Small Cell Lung Cancer
por: Chung, Eun Ki, et al.
Publicado: (2023)

A Case of Residual Non-Small Cell Lung Cancer Cells Coexisting With Newly Developed Small Cell Lung Cancer Cells in Ascitic Fluid after Chemotherapy for Non-Small Cell Lung Cancer
por: Park, Sang Hyuk, et al.
Publicado: (2014)

Pemetrexed versus Gefitinib versus Erlotinib in Previously Treated Patients with Non-Small Cell Lung Cancer
por: Hong, Junshik, et al.
Publicado: (2010)

Analysis of immune subtypes in non-small-cell lung cancer based on TCGA database
por: Xie, Xuexue, et al.
Publicado: (2023)

Multiplatform-based Molecular Subtypes of Non-Small Cell Lung Cancer
por: Chen, Fengju, et al.
Publicado: (2016)

Proportion and clinical features of never-smokers with non-small cell lung cancer
por: Cho, Jaeyoung, et al.
Publicado: (2017)

Clinical implication of interstitial lung abnormality in elderly patients with early‐stage non‐small cell lung cancer
por: Cho, Seong Woo, et al.
Publicado: (2022)

Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis
por: Chun, Sang Hoon, et al.
Publicado: (2011)

Cost-Effectiveness Analysis of Three Diagnostic Strategies for the Detection of EGFR Mutation in Advanced Non-Small Cell Lung Cancer
por: Cho, Sun Mi, et al.
Publicado: (2023)

Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer
por: Choi, Chang-Min, et al.
Publicado: (2011)

Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer
por: Cho, Jae-Won, et al.
Publicado: (2020)

Psoriasiform Dermatitis Related with T-Cell Immunoreceptor with Immunoglobulin and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains Inhibitor in a Patient with Non-Small-Cell Lung Cancer
por: Choi, YoungHwan, et al.
Publicado: (2020)

Real-World Study of Osimertinib in Korean Patients with Epidermal Growth Factor Receptor T790M Mutation–Positive Non–Small Cell Lung Cancer
por: Lee, Jang Ho, et al.
Publicado: (2023)

Molecular Subtypes and Tumor Microenvironment Characteristics of Small-Cell Lung Cancer Associated with Platinum-Resistance
por: Kim, Jihyun, et al.
Publicado: (2023)

The Value of Residual Volume/Total Lung Capacity as an Indicator for Predicting Postoperative Lung Function in Non-Small Lung Cancer
por: Kwon, Oh-Beom, et al.
Publicado: (2021)

Combined pulmonary fibrosis and emphysema and idiopathic pulmonary fibrosis in non-small cell lung cancer: impact on survival and acute exacerbation
por: Moon, Sung Woo, et al.
Publicado: (2019)

Real-world experience of afatinib as first-line therapy for advanced EGFR mutation-positive non-small cell lung cancer in Korea
por: Lee, Sung Yong, et al.
Publicado: (2021)

TP53 Mutations in Korean Patients with Non-small Cell Lung Cancer
por: Lee, Eung Bae, et al.
Publicado: (2010)

Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
por: Lim, Sun Min, et al.
Publicado: (2020)

Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer
por: Judd, Julia, et al.
Publicado: (2021)

Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer
por: Min, Hye-Young, et al.
Publicado: (2015)

Impaired AKT signaling and lung tumorigenesis by PIERCE1 ablation in KRAS-mutant non-small cell lung cancer
por: Roh, Jae-il, et al.
Publicado: (2020)

Lymph Node Metastasis after Spontaneous Regression of Non-Small Cell Lung Cancer
por: Jeong, Jae Hwa, et al.
Publicado: (2019)

EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer
por: Jin, Guang, et al.
Publicado: (2012)

Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer
por: Park, Cheol-Kyu, et al.
Publicado: (2023)

The relationship between the severity of pulmonary fibrosis and the lung cancer stage
por: Jang, Hye Jin, et al.
Publicado: (2021)

An Array-Based Approach to Determine Different Subtype and Differentiation of Non-Small Cell Lung Cancer
por: Li, Chao, et al.
Publicado: (2015)

Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
por: Lee, Dong-Soo, et al.
Publicado: (2011)

Distinctive Patterns of Initially Presenting Metastases and Clinical Outcomes According to the Histological Subtypes in Stage IV Non-Small Cell Lung Cancer
por: Lee, Dong Soo, et al.
Publicado: (2016)

Immunohistochemical Analysis of Non-Small Cell Lung Cancer: Correlation with Clinical Parameters and Prognosis
por: Yoo, Jinyoung, et al.
Publicado: (2007)

Immune Regulatory Function of Cancer-Associated Fibroblasts in Non-small Cell Lung Cancer
por: Lee, Hyewon, et al.
Publicado: (2023)

Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
por: Park, Ji Eun, et al.
Publicado: (2020)

Low-level expression of necroptosis factors indicates a poor prognosis of the squamous cell carcinoma subtype of non-small-cell lung cancer
por: Lim, Jun Hyeok, et al.
Publicado: (2021)

Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factors
por: Kim, Jehun, et al.
Publicado: (2023)

Parkinson’s Disease Subtyping Using Clinical Features and Biomarkers: Literature Review and Preliminary Study of Subtype Clustering
por: Lee, Seung Hyun, et al.
Publicado: (2022)

Association of PARP1-specific polymorphisms and haplotypes with non-small cell lung cancer subtypes
por: Jin, Jing, et al.
Publicado: (2020)

Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
por: Lee, Jin Gu, et al.
Publicado: (2015)

Integrated analysis of EGFR mutated non‐small cell lung cancer reveals two distinct molecular subtypes
por: Bai, Menglin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3259pkfe5fevpq538lca4ut64h